EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Diagnostic accuracy of circulating microRNAs and lipidomic biomarkers for early breast cancer detection: A systematic review and meta-analysis

Heba Mohammed Arafat iD, Akbar Ali, Tengku Ahmad Damitri Al Astani Tengku Din, Ohood Mohammed Shamallakh, Rashid Jusoh, Maya Mazuwin Yahya, Wan Zainira Wan Zain, Wan Faiziah Wan Abdul Rahman

PLOS One · 24.07.2026 · 21 (7) · e0354728

DOI: 10.1371/journal.pone.0354728 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS One, online erschienen am 24.07.2026. Verfasst von Heba Mohammed Arafat und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. Hauptthemen laut MEDLINE: Breast Neoplasms, Biomarkers, Tumor, Circulating MicroRNA, Early Detection of Cancer. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer outcomes improve substantially with earlier detection, yet mammography performance can be limited in dense breasts and may lead to false-positive investigations. Circulating microRNAs (miRNAs) and lipidomic/metabolomic signatures have emerged as promising minimally invasive biomarkers that could complement imaging for early-stage detection. The aim of this systematic review and meta-analysis is to evaluate the diagnostic accuracy of circulating microRNAs and lipidomic/metabolomic biomarkers for early breast cancer detection and to explore between-study heterogeneity. Materials and methods A PRISMA 2020–compliant systematic review and meta-analysis were conducted. MEDLINE (PubMed), Web of Science, Scopus, Springer, ScienceDirect, and the Cochrane Library were searched for eligible diagnostic studies assessing circulating microRNAs and lipidomic/metabolomic biomarkers measured in serum or plasma. No language restrictions were applied. Non-English reports were screened and, when potentially eligible, translated for full-text assessment and data extraction. Studies using whole blood were excluded. Study quality was assessed using QUADAS-2. Random-effects models (DerSimonian–Laird) pooled sensitivity, specificity, likelihood ratios, diagnostic odds ratio (DOR), and summary ROC (SROC) area under the curve (AUC). Heterogeneity was evaluated using Q and I 2 statistics, and small-study effects were assessed using Deeks’ test.

Results

Thirty-two studies (2015–2025) comprising 6,935 participants (3,697 breast cancer cases; 3,238 controls) were included. Pooled sensitivity was 0.87 (95% CI [0.83, 0.90]) and pooled specificity was 0.84 (95% CI [0.79, 0.88]), with pooled DOR 46.10 (95% CI [27.80, 76.70]), PLR 5.17 (95% CI [3.99, 6.68]), NLR 0.16 (95% CI [0.13, 0.21]), and SROC AUC 0.92 (95% CI [0.87, 0.94]). Heterogeneity was substantial (I 2 = 88.29% for sensitivity; I 2 = 90.20% for specificity). In subgroup analyses, serum-based studies showed higher pooled specificity than plasma-based studies. A formal threshold effect assessment did not reveal a statistically significant correlation between sensitivity and false-positive rate (Spearman ρ = − 0.334, p = 0.062). Deeks’ test suggested potential small-study effects (p = 0.043).

Conclusions

Circulating microRNA and lipidomic/metabolomic biomarkers demonstrate strong overall diagnostic performance for breast cancer detection; however, substantial heterogeneity and potential small-study effects limit their immediate clinical translation. Given that most included studies used retrospective case-control designs rather than prospective screening cohorts, these biomarkers are best regarded as investigational, complementary tools rather than replacements for mammography at this stage. Future large, prospective, standardized studies with harmonized pre-analytics and prespecified thresholds are needed to support the implementation of screening or triage pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsBiomarkers, TumorCirculating MicroRNAEarly Detection of CancerLipidomicsHumansFemaleSensitivity and Specificity

Substanzen

Biomarkers, TumorCirculating MicroRNA

Autor:innen und Institutionen

  • Department of Chemical Pathology, School of Medical Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
  • Breast Cancer Awareness and Research Unit, Hospital Pakar Universiti Sains Malaysia, Health Campus, Kubang Kerian, Kelantan, Malaysia.
  • Department of Medical Laboratory Sciences, Faculty of Health Sciences, Islamic University of Gaza, Gaza City, Palestine.
  • Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian, Kelantan, Malaysia.
  • Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, Health Campus, Kubang Kerian, Kelantan, Malaysia.

ORCID-Profile: Heba Mohammed Arafat

Zitieren

APA

Arafat, H. M., Ali, A., Tengku Din, T. A. D. A. A., Shamallakh, O. M., Jusoh, R., Yahya, M. M., Zain, W. Z. W., & Rahman, W. F. W. A. (2026). Diagnostic accuracy of circulating microRNAs and lipidomic biomarkers for early breast cancer detection: A systematic review and meta-analysis. PLOS One, 21(7), e0354728. https://doi.org/10.1371/journal.pone.0354728

Vancouver

Arafat HM, Ali A, Tengku Din TADAA, Shamallakh OM, Jusoh R, Yahya MM, et al. Diagnostic accuracy of circulating microRNAs and lipidomic biomarkers for early breast cancer detection: A systematic review and meta-analysis. PLOS One. 2026;21(7):e0354728. doi:10.1371/journal.pone.0354728

BibTeX
@article{Arafat2026,
  author = {Arafat, Heba Mohammed and Ali, Akbar and Tengku Din, Tengku Ahmad Damitri Al Astani and Shamallakh, Ohood Mohammed and Jusoh, Rashid and Yahya, Maya Mazuwin and Zain, Wan Zainira Wan and Rahman, Wan Faiziah Wan Abdul},
  title = {Diagnostic accuracy of circulating microRNAs and lipidomic biomarkers for early breast cancer detection: A systematic review and meta-analysis},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0354728},
  doi = {10.1371/journal.pone.0354728}
}
Kostenlos starten →